Clinical Trial Update: A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD) [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the efficacy of guselkumab in Chinese participants with Crohn's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Crohn Disease | Phase 4 | Status: RECRUITING